Literature DB >> 29762630

Acute-on-Chronic Liver Failure in China: Rationale for Developing a Patient Registry and Baseline Characteristics.

Wen-Yi Gu1,2,3, Bao-Yan Xu4,5, Xin Zheng5,6, Jinjun Chen5,7, Xian-Bo Wang5,8, Yan Huang5,9, Yan-Hang Gao5,10, Zhong-Ji Meng5,11, Zhi-Ping Qian5,12, Feng Liu5,13, Xiao-Bo Lu5,14, Jia Shang3,15, Hai Li1,2,3,5,16, Shao-Yang Wang17, Xin Sun18, Hai Li1,2,3,5,16.   

Abstract

Definitions and descriptions of acute-on-chronic liver failure (ACLF) vary between Western and Eastern types, and alcoholism and hepatitis B virus (HBV) are, respectively, the main etiologies. To determine whether there are unified diagnostic criteria and common treatment programs for different etiologies of ACLF, a multicenter prospective cohort with the same inclusion criteria and disease indicators as those used in the European Consortium Acute-on-Chronic Liver Failure in Cirrhosis Study is urgently needed in Asia, where the prevalence of HBV is high. A multicenter prospective cohort of 2,600 patients was designed, drawing from 14 nationwide liver centers from tertiary university hospitals in China, and 2,600 hospitalized patients with chronic liver disease (both cirrhotic and noncirrhotic) of various etiologies with acute decompensation or acute hepatic injury were continuously recruited from January 2015 to December 2016. Data were collected during hospitalization, and follow-ups were performed once a month, with plans to follow all patients until 36 months after hospital discharge. Of these patients, 1,859 (71.5%) had HBV-related disease, 1,833 had cirrhotic disease, and 767 had noncirrhotic disease. The numbers and proportions of enrolled patients from each participating center and the baseline characteristics of the patients with or without cirrhosis are presented.

Entities:  

Mesh:

Year:  2018        PMID: 29762630     DOI: 10.1093/aje/kwy083

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

Review 1.  Definition and classification of acute-on-chronic liver diseases.

Authors:  Yuan-Yao Zhang; Zhong-Ji Meng
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

2.  Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure.

Authors:  Na Hu; Xian-Ci Xie; Lin-Lin Liu; Wei-Dong Lai
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

3.  Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure.

Authors:  Xiju Guo; Fengqing Wu; Weibo Guo; Jiachang Zhang; Yan Yang; Yajing Lu; Congbo Yin; Hongxing Fan; Juan Xu; Mingmei Liao
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

4.  Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study.

Authors:  Xin Sun; Hai Li; Liang Qiao; Xianbo Wang; Guohong Deng; Yan Huang; Jinjun Chen; Zhongji Meng; Xin Zheng; Yu Shi; Zhiping Qian; Feng Liu; Yanhang Gao; Xiaobo Lu; Junping Liu; Wenyi Gu; Yan Zhang; Tongyu Wang; Dandan Wu; Fuchen Dong
Journal:  BMJ Open       Date:  2021-01-08       Impact factor: 2.692

5.  A novel prognostic model to predict outcome of artificial liver support system treatment.

Authors:  Jin Shang; Mengqiao Wang; Qin Wen; Yuanji Ma; Fang Chen; Yan Xu; Chang-Hai Liu; Lang Bai; Hong Tang
Journal:  Sci Rep       Date:  2021-04-05       Impact factor: 4.996

6.  Prevalence and clinical significance of serum sodium variability in patients with acute-on-chronic liver diseases: a prospective multicenter study in China.

Authors:  Xue Mei; Hai Li; Guohong Deng; Xianbo Wang; Xin Zheng; Yan Huang; Jinjun Chen; Zhongji Meng; Yanhang Gao; Feng Liu; Xiaobo Lu; Yu Shi; Yubao Zheng; Huadong Yan; Weituo Zhang; Liang Qiao; Wenyi Gu; Yan Zhang; Xiaomei Xiang; Yi Zhou; Shuning Sun; Yixin Hou; Qun Zhang; Yan Xiong; Congcong Zou; Jun Chen; Zebing Huang; Beiling Li; Xiuhua Jiang; Guotao Zhong; Haiyu Wang; Yuanyuan Chen; Sen Luo; Na Gao; Chunyan Liu; Jing Li; Tao Li; Rongjiong Zheng; Xinyi Zhou; Haotang Ren; Wei Yuan; Zhiping Qian
Journal:  Hepatol Int       Date:  2022-01-17       Impact factor: 9.029

7.  Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation.

Authors:  Ying Zhu; Hai Li; Xianbo Wang; Xin Zheng; Yan Huang; Jinjun Chen; Zhongji Meng; Yanhang Gao; Zhiping Qian; Feng Liu; Xiaobo Lu; Yu Shi; Jia Shang; Huadong Yan; Yubao Zheng; Liang Qiao; Yan Zhang; Xiaomei Xiang; Yunjie Dan; Shuning Sun; Yixin Hou; Qun Zhang; Yan Xiong; Sumeng Li; Jun Chen; Zebing Huang; Beiling Li; Xiuhua Jiang; Sen Luo; Yuanyuan Chen; Na Gao; Chunyan Liu; Liujuan Ji; Wei Yuan; Jing Li; Tao Li; Rongjiong Zheng; Xinyi Zhou; Haotang Ren; Yi Zhou; Baoyan Xu; Rentao Yu; Wenting Tan; Guohong Deng
Journal:  Front Microbiol       Date:  2022-07-07       Impact factor: 6.064

Review 8.  Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions.

Authors:  Jingfeng Liu; Zhiming Yuan; Qingwen Wang
Journal:  J Clin Transl Hepatol       Date:  2022-03-09

9.  Different Effects of Total Bilirubin on 90-Day Mortality in Hospitalized Patients With Cirrhosis and Advanced Fibrosis: A Quantitative Analysis.

Authors:  Liang Qiao; Wenting Tan; Xiaobo Wang; Xin Zheng; Yan Huang; Beiling Li; Zhongji Meng; Yanhang Gao; Zhiping Qian; Feng Liu; Xiaobo Lu; Jia Shang; Junping Liu; Huadong Yan; Wenyi Gu; Yan Zhang; Xiaomei Xiang; Yixin Hou; Qun Zhang; Yan Xiong; Congcong Zou; Jun Chen; Zebing Huang; Xiuhua Jiang; Sen Luo; Yuanyuan Chen; Na Gao; Chunyan Liu; Wei Yuan; Xue Mei; Jing Li; Tao Li; Rongjiong Zheng; Xinyi Zhou; Jinjun Chen; Guohong Deng; Weituo Zhang; Hai Li
Journal:  Front Med (Lausanne)       Date:  2021-06-23

10.  Infection deteriorating hepatitis B virus related acute-on-chronic liver failure: a retrospective cohort study.

Authors:  Xing-Ran Zhai; Jing-Jing Tong; Hong-Min Wang; Xiang Xu; Xiu-Ying Mu; Jing Chen; Zi-Feng Liu; Yu Wang; Hai-Bin Su; Jin-Hua Hu
Journal:  BMC Gastroenterol       Date:  2020-09-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.